Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 30 Myelodysplastic Syndromes 10 Recurrence 5 Leukemia, Myelomonocytic, Chronic 4 Leukemia 4 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Extranodal NK-T-Cell 2 Hematologic Neoplasms 2 Anemia, Refractory, with Excess of Blasts 2 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Lymphohistiocytosis, Hemophagocytic 1 Leukemia, Myeloid 1 Glioma 1 Frailty 1 Burkitt Lymphoma 1

Interventions

Temozolomide 16 Radiotherapy 7 apatinib 5 anlotinib 3 Surgical Procedures, Operative 3 Chlorotoxin 3 Bevacizumab 3 Aminolevulinic Acid 3 Positron Emission Tomography Computed Tomography 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2 Lomustine 2 Irinotecan 2 Immunotherapy, Adoptive 2 Blood Specimen Collection 2 vandetanib 1 sodium thiosulfate 1 ribociclib 1 poly ICLC 1 lonafarnib 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 etoposide phosphate 1 Vinblastine 1 Valproic Acid 1 Tranexamic Acid 1 Surveys and Questionnaires 1 Sunitinib 1 Rivaroxaban 1 Radiosurgery 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Glioma × Azacitidine × Clear all

NCT03666559 2024-02-29

AGIR

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡